Because the systemic bioavailability of NASONEX Aqueous Nasal Spray is <1% (using a sensitive assay with a lower quantitation limit of 0.25 pg/mL), overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage.
Inhalation or oral administration of excessive doses of corticosteroids may lead to suppression of Hypothalamic-Pituitary-Adrenal axis function.
Other Services
Country
Account